{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:54:48Z","timestamp":1794272088103,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-19-P3IA-0001"],"award-info":[{"award-number":["ANR-19-P3IA-0001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["ZO1 AG000949"],"award-info":[{"award-number":["ZO1 AG000949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cognitive decline is common in Parkinson\u2019s disease (PD) and its genetic risk factors are not well known to date, besides variants in the <jats:italic>GBA<\/jats:italic> and <jats:italic>APOE<\/jats:italic> genes. However, variation in complex traits is caused by numerous variants and is usually studied with genome-wide association studies (GWAS), requiring a large sample size, which is difficult to achieve for outcome measures in PD. Taking an alternative approach, we computed 100 polygenic scores (PGS) related to cognitive, dementia, stroke, and brain anatomical phenotypes and investigated their association with cognitive decline in six longitudinal cohorts. The analysis was adjusted for age, sex, genetic ancestry, follow-up duration, <jats:italic>GBA<\/jats:italic> and <jats:italic>APOE<\/jats:italic> status. Then, we meta-analyzed five of these cohorts, comprising a total of 1702 PD participants with 6156 visits, using the Montreal Cognitive Assessment as a cognitive outcome measure. After correction for multiple comparisons, we found four PGS significantly associated with cognitive decline: intelligence (<jats:italic>p<\/jats:italic>\u2009=\u20095.26e\u201313), cognitive performance (<jats:italic>p<\/jats:italic>\u2009=\u20091.46e\u201312), educational attainment (<jats:italic>p<\/jats:italic>\u2009=\u20098.52e\u201310), and reasoning (<jats:italic>p<\/jats:italic>\u2009=\u20093.58e\u20135). Survival analyses highlighted an offset of several years between the first and last quartiles of PGS, with significant differences for the PGS of cognitive performance (5 years) and educational attainment (7 years). In conclusion, we found four PGS associated with cognitive decline in PD, all associated with general cognitive phenotypes. This study highlights the common genetic factors between cognitive decline in PD and the general population, and the importance of the participant\u2019s cognitive reserve for cognitive outcome in PD.<\/jats:p>","DOI":"10.1038\/s41531-023-00619-5","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:03:15Z","timestamp":1704373395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proxy-analysis of the genetics of cognitive decline in Parkinson\u2019s disease through polygenic scores"],"prefix":"10.1038","volume":"10","author":[{"given":"Johann","family":"Faouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5835-669X","authenticated-orcid":false,"given":"Manuela","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Casse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Tesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2847-3067","authenticated-orcid":false,"given":"Graziella","family":"Mangone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-1223","authenticated-orcid":false,"given":"Louise-Laure","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9836-654X","authenticated-orcid":false,"given":"Olivier","family":"Colliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Pihlstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-0199","authenticated-orcid":false,"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/mds.23823","volume":"26","author":"I Litvan","year":"2011","unstructured":"Litvan, I. et al. MDS task force on mild cognitive impairment in Parkinson\u2019s disease: Critical review of PD-MCI. Mov. Disord. 26, 1814\u20131824 (2011).","journal-title":"Mov. Disord."},{"key":"619_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano, C., Barone, P., Trojano, L. & Santangelo, G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: A meta-analysis. Mov. Disord. 35, 45\u201354 (2020).","journal-title":"Mov. Disord."},{"key":"619_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1212\/01.WNL.0000036610.36834.E0","volume":"59","author":"G Levy","year":"2002","unstructured":"Levy, G. et al. The association of incident dementia with mortality in PD. Neurology 59, 1708\u20131713 (2002).","journal-title":"Neurology"},{"key":"619_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland, D. et al. Cognitive decline in Parkinson\u2019s disease. Nat. Rev. Neurol. 13, 217\u2013231 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"619_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/ene.13258","volume":"24","author":"ES Fagan","year":"2017","unstructured":"Fagan, E. S. & Pihlstr\u00f8m, L. Genetic risk factors for cognitive decline in Parkinson\u2019s disease: a review of the literature. Eur. J. Neurol. 24, 561\u2013e20 (2017).","journal-title":"Eur. J. Neurol."},{"key":"619_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska, K. S., LaMarca, M. E., Scott, C. R. & Sidransky, E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum. Mutat. 29, 567\u2013583 (2008).","journal-title":"Hum. Mutat."},{"key":"619_CR7","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","volume":"78","author":"RN Alcalay","year":"2012","unstructured":"Alcalay, R. N. et al. Cognitive performance of GBA mutation carriers with early-onset PD. Neurology 78, 1434\u20131440 (2012).","journal-title":"Neurology"},{"key":"619_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/mds.24045","volume":"27","author":"N Set\u00f3-Salvia","year":"2012","unstructured":"Set\u00f3-Salvia, N. et al. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson\u2019s disease course. Mov. Disord. 27, 393\u2013399 (2012).","journal-title":"Mov. Disord."},{"key":"619_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/brain\/aws318","volume":"136","author":"SE Winder-Rhodes","year":"2013","unstructured":"Winder-Rhodes, S. E. et al. Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort. Brain 136, 392\u2013399 (2013).","journal-title":"Brain"},{"key":"619_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata, I. F. et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson\u2019s disease. Mov. Disord. 31, 95\u2013102 (2016).","journal-title":"Mov. Disord."},{"key":"619_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","volume":"53","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease. Nat. Genet 53, 787\u2013793 (2021).","journal-title":"Nat. Genet"},{"key":"619_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki, Y. et al. and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501\u2013518 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","volume":"256","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray, C. H. et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease. J. Neurol. 256, 493\u2013498 (2009).","journal-title":"J. Neurol."},{"key":"619_CR14","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/brain\/awu201","volume":"137","author":"C Nombela","year":"2014","unstructured":"Nombela, C. et al. Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain 137, 2743\u20132758 (2014).","journal-title":"Brain"},{"key":"619_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mds.24946","volume":"27","author":"JF Morley","year":"2012","unstructured":"Morley, J. F. et al. Genetic influences on cognitive decline in Parkinson\u2019s disease. Mov. Disord. 27, 512\u2013518 (2012).","journal-title":"Mov. Disord."},{"key":"619_CR16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","volume":"71","author":"IF Mata","year":"2014","unstructured":"Mata, I. F. et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson\u2019s disease. JAMA Neurol. 71, 1405\u20131412 (2014).","journal-title":"JAMA Neurol."},{"key":"619_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","volume":"6","author":"KC Paul","year":"2016","unstructured":"Paul, K. C. et al. APOE, MAPT, and COMT and Parkinson\u2019s disease susceptibility and cognitive symptom progression. J. Parkinsons Dis. 6, 349\u2013359 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"619_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/mds.26161","volume":"30","author":"S Srivatsal","year":"2015","unstructured":"Srivatsal, S. et al. Cognitive profile of LRRK2-related Parkinson\u2019s disease. Mov. Disord. 30, 728\u2013733 (2015).","journal-title":"Mov. Disord."},{"key":"619_CR19","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/mds.23746","volume":"26","author":"V Shanker","year":"2011","unstructured":"Shanker, V. et al. Mood and cognition in Leucine-rich repeat Kinase 2 G2019S Parkinson\u2019s disease. Mov. Disord. 26, 1875\u20131880 (2011).","journal-title":"Mov. Disord."},{"key":"619_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.parkreldis.2011.10.009","volume":"18","author":"S Ben Sassi","year":"2012","unstructured":"Ben Sassi, S. et al. Cognitive dysfunction in Tunisian LRRK2 associated Parkinson\u2019s disease. Parkinsonism Relat. Disord. 18, 243\u2013246 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"619_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","volume":"310","author":"JH Somme","year":"2011","unstructured":"Somme, J. H. et al. Initial neuropsychological impairments in patients with the E46K mutation of the \u03b1-synuclein gene (PARK 1). J. Neurol. Sci. 310, 86\u201389 (2011).","journal-title":"J. Neurol. Sci."},{"key":"619_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000352033","volume":"70","author":"M Svetel","year":"2013","unstructured":"Svetel, M. et al. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson\u2019s disease. Eur. Neurol. 70, 257\u2013262 (2013).","journal-title":"Eur. Neurol."},{"key":"619_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2013.12.051","volume":"561","author":"M Bia\u0142ecka","year":"2014","unstructured":"Bia\u0142ecka, M. et al. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson\u2019s disease. Neurosci. Lett. 561, 86\u201390 (2014).","journal-title":"Neurosci. Lett."},{"key":"619_CR24","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.27845","volume":"34","author":"H Iwaki","year":"2019","unstructured":"Iwaki, H. et al. Genomewide association study of Parkinson\u2019s disease clinical biomarkers in 12 longitudinal patients\u2019 cohorts. Mov. Disord. 34, 1839\u20131850 (2019).","journal-title":"Mov. Disord."},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"579268","DOI":"10.3389\/fneur.2020.579268","volume":"11","author":"KW Park","year":"2020","unstructured":"Park, K. W. et al. Genomic association study for cognitive impairment in Parkinson\u2019s disease. Front Neurol. 11, 579268 (2020).","journal-title":"Front Neurol."},{"key":"619_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","volume":"36","author":"MMX Tan","year":"2021","unstructured":"Tan, M. M. X. et al. Genome-wide association studies of cognitive and motor progression in Parkinson\u2019s disease. Mov. Disord. 36, 424\u2013433 (2021).","journal-title":"Mov. Disord."},{"key":"619_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43458-2","volume":"9","author":"A Rongve","year":"2019","unstructured":"Rongve, A. et al. GBA and APOE \u03b54 associate with sporadic dementia with Lewy bodies in European genome wide association study. Sci. Rep. 9, 7013 (2019).","journal-title":"Sci. Rep."},{"key":"619_CR28","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/genes12121975","volume":"12","author":"S Jo","year":"2021","unstructured":"Jo, S. et al. Microarray genotyping identifies new Loci associated with Dementia in Parkinson\u2019s disease. Genes 12, 1975 (2021).","journal-title":"Genes"},{"key":"619_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/brain\/awac327","volume":"146","author":"G Liu","year":"2023","unstructured":"Liu, G. et al. Mitochondrial haplogroups and cognitive progression in Parkinson\u2019s disease. Brain 146, 42\u201349 (2023).","journal-title":"Brain"},{"key":"619_CR30","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in \u223c700,000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641\u20133649 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"619_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/hmg\/ddy327","volume":"28","author":"SL Pulit","year":"2019","unstructured":"Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166\u2013174 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"619_CR32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/mp.2016.45","volume":"21","author":"G Davies","year":"2016","unstructured":"Davies, G. et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112151). Mol. Psychiatry 21, 758\u2013767 (2016).","journal-title":"Mol. Psychiatry"},{"key":"619_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04362-x","volume":"9","author":"G Davies","year":"2018","unstructured":"Davies, G. et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat. Commun. 9, 2098 (2018).","journal-title":"Nat. Commun."},{"key":"619_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41588-018-0147-3","volume":"50","author":"JJ Lee","year":"2018","unstructured":"Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet. 50, 1112\u20131121 (2018).","journal-title":"Nat. Genet."},{"key":"619_CR35","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41588-018-0152-6","volume":"50","author":"JE Savage","year":"2018","unstructured":"Savage, J. E. et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat. Genet. 50, 912\u2013919 (2018).","journal-title":"Nat. Genet."},{"key":"619_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"619_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"619_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat. Genet. 53, 392\u2013402 (2021).","journal-title":"Nat. Genet."},{"key":"619_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia, R. et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat. Genet. 53, 294\u2013303 (2021).","journal-title":"Nat. Genet."},{"key":"619_CR40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524\u2013537 (2018).","journal-title":"Nat. Genet."},{"key":"619_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343\u2013352 (2019).","journal-title":"Nat. Neurosci."},{"key":"619_CR42","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/mp.2015.197","volume":"21","author":"T Otowa","year":"2016","unstructured":"Otowa, T. et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol. Psychiatry 21, 1391\u20131399 (2016).","journal-title":"Mol. Psychiatry"},{"key":"619_CR43","unstructured":"Neale lab. UK Biobank. Neale lab http:\/\/www.nealelab.is\/uk-biobank (2018)."},{"key":"619_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19111-2","volume":"11","author":"M Sargurupremraj","year":"2020","unstructured":"Sargurupremraj, M. et al. Cerebral small vessel disease genomics and its implications across the lifespan. Nat. Commun. 11, 6285 (2020).","journal-title":"Nat. Commun."},{"key":"619_CR45","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4398","volume":"19","author":"HHH Adams","year":"2016","unstructured":"Adams, H. H. H. et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat. Neurosci. 19, 1569\u20131582 (2016).","journal-title":"Nat. Neurosci."},{"key":"619_CR46","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41588-019-0511-y","volume":"51","author":"CL Satizabal","year":"2019","unstructured":"Satizabal, C. L. et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat. Genet. 51, 1624\u20131636 (2019).","journal-title":"Nat. Genet."},{"key":"619_CR47","doi-asserted-by":"publisher","first-page":"eaay6690","DOI":"10.1126\/science.aay6690","volume":"367","author":"KL Grasby","year":"2020","unstructured":"Grasby, K. L. et al. The genetic architecture of the human cerebral cortex. Science 367, eaay6690 (2020).","journal-title":"Science"},{"key":"619_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1283-z","volume":"17","author":"R Perneczky","year":"2019","unstructured":"Perneczky, R. et al. Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer\u2019s Association Reserve, Resilience and Protective Factors Professional Interest Area working groups. BMC Med 17, 47 (2019).","journal-title":"BMC Med"},{"key":"619_CR49","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1007\/s10072-022-05985-1","volume":"43","author":"L Gu","year":"2022","unstructured":"Gu, L. & Xu, H. Effect of cognitive reserve on cognitive function in Parkinson\u2019s disease. Neurol. Sci. 43, 4185\u20134192 (2022).","journal-title":"Neurol. Sci."},{"key":"619_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40520-017-0838-0","volume":"30","author":"N Ciccarelli","year":"2018","unstructured":"Ciccarelli, N. et al. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson\u2019s disease. Aging Clin. Exp. Res 30, 877\u2013880 (2018).","journal-title":"Aging Clin. Exp. Res"},{"key":"619_CR51","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/mds.27854","volume":"34","author":"P-C Lee","year":"2019","unstructured":"Lee, P.-C. et al. Examining the reserve hypothesis in Parkinson\u2019s disease: a longitudinal study. Mov. Disord. 34, 1663\u20131671 (2019).","journal-title":"Mov. Disord."},{"key":"619_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.14336\/AD.2018.0125","volume":"9","author":"CP-W Cheng","year":"2018","unstructured":"Cheng, C. P.-W. et al. Relationship between cortical thickness and neuropsychological performance in normal older adults and those with mild cognitive impairment. Aging Dis. 9, 1020\u20131030 (2018).","journal-title":"Aging Dis."},{"key":"619_CR53","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","volume":"91","author":"J-C Corvol","year":"2018","unstructured":"Corvol, J.-C. et al. Longitudinal analysis of impulse control disorders in Parkinson\u2019s disease. Neurology 91, e189\u2013e201 (2018).","journal-title":"Neurology"},{"key":"619_CR54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.parkreldis.2021.02.023","volume":"85","author":"V Czernecki","year":"2021","unstructured":"Czernecki, V. et al. Social cognitive impairment in early Parkinson\u2019s disease: A novel \u201cmild impairment\u201d? Parkinsonism Relat. Disord. 85, 117\u2013121 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"619_CR55","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/mds.28549","volume":"36","author":"H Iwaki","year":"2021","unstructured":"Iwaki, H. et al. Accelerating medicines partnership: Parkinson\u2019s disease. Genetic resource. Mov. Disord. 36, 1795\u20131804 (2021).","journal-title":"Mov. Disord."},{"key":"619_CR56","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops, S. et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson\u2019s disease. Neurology 73, 1738\u20131745 (2009).","journal-title":"Neurology"},{"key":"619_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"619_CR58","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279\u20131283 (2016).","journal-title":"Nat. Genet."},{"key":"619_CR59","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"619_CR60","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-022-02511-7","volume":"129","author":"G H\u00f6glinger","year":"2022","unstructured":"H\u00f6glinger, G. et al. GBA-associated PD: chances and obstacles for targeted treatment strategies. J. Neural Transm. 129, 1219\u20131233 (2022).","journal-title":"J. Neural Transm."},{"key":"619_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu, C.-C., Kanekiyo, T., Xu, H., Bu, G. & Apolipoprotein, E. and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"619_CR62","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47, D1005\u2013D1012 (2019).","journal-title":"Nucleic Acids Res"},{"key":"619_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2020.00047","volume":"11","author":"S Sasikumar","year":"2020","unstructured":"Sasikumar, S. & Strafella, A. P. Imaging mild cognitive impairment and dementia in Parkinson\u2019s disease. Front Neurol. 11, 47 (2020).","journal-title":"Front Neurol."},{"key":"619_CR64","doi-asserted-by":"publisher","first-page":"e51168","DOI":"10.7554\/eLife.51168","volume":"9","author":"TSH J\u00f8rgensen","year":"2020","unstructured":"J\u00f8rgensen, T. S. H., Okholm, G. T., Christensen, K., S\u00f8rensen, T. I. & Osler, M. Body height in young adult men and risk of dementia later in adult life. eLife 9, e51168 (2020).","journal-title":"eLife"},{"key":"619_CR65","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1093\/bioinformatics\/btaa1029","volume":"36","author":"F Priv\u00e9","year":"2020","unstructured":"Priv\u00e9, F., Arbel, J. & Vilhj\u00e1lmsson, B. J. LDpred2: better, faster, stronger. Bioinformatics 36, 5424\u20135431 (2020).","journal-title":"Bioinformatics"},{"key":"619_CR66","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.biopsych.2021.04.018","volume":"90","author":"G Ni","year":"2021","unstructured":"Ni, G. et al. A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts. Biol. Psychiatry 90, 611\u2013620 (2021).","journal-title":"Biol. Psychiatry"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00619-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:13:09Z","timestamp":1704373989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00619-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Johann Faouzi\u2014<i>Reports no disclosures<\/i>. Manuela Tan\u2014<i>Reports no disclosures<\/i>. Fanny Casse\u2014<i>Reports no disclosures<\/i>. Suzanne Lesage\u2014<i>Reports no disclosures<\/i>. Christelle Tesson\u2014<i>Reports no disclosures<\/i>. Alexis Brice\u2014<i>Reports no disclosures<\/i>. Graziella Mangone\u2014<i>Reports no disclosures<\/i>. Louise-Laure Mariani\u2014<i>Reports no disclosures related to the present work<\/i>. Competing financial interests unrelated to the present work: received research support grants from INSERM, JNLF, The L\u2019Oreal Foundation, the French Parkinson Association, Fondation of France, Paris Brain Institute BBT and Neurocatalyst calls; speech honoraria from CSL, Sanofi-Genzyme, Lundbeck, Teva; consultant for Accure therapeutics, Sanofi and received travel funding from the Movement Disorders Society, ANAINF, Merck, Merz, Medtronic, Teva and AbbVie, outside the submitted work. Hirotaka Iwaki\u2014<i>Reports no disclosures related to the present work<\/i>. Olivier Colliot\u2014<i>Reports no disclosures related to the present work<\/i>. Competing financial interests unrelated to the present work: O.C. received consulting fees from AskBio and Therapanacea and received fees for writing a lay audience short paper from Expression Sant\u00e9. His laboratory received grants (paid to the institution) from Qynapse. Members from his laboratory have co-supervised a PhD thesis with myBrainTechnologies. O.C.\u2019s spouse is an employee of myBrainTechnologies. O.C. holds a patent registered at the International Bureau of the World Intellectual Property Organization (PCT\/IB2016\/0526993, Schiratti J-B, Allassonniere S, Colliot O, Durrleman S, A method for determining the temporal progression of a biological phenomenon and associated methods and devices). Lasse Pihlstr\u00f8m\u2014<i>Reports no disclosures related to the present work<\/i>. Has served as consultant for Roche, for which a fee was paid to his institution, and received grants from the South-Eastern Regional Health Authority, Norway, National Health Association, Norway and the Michael J. Fox Foundation. Jean-Christophe Corvol\u2014<i>Reports no disclosures related to the present work<\/i>. Has served in scientific advisory boards for Biogen, Denali, Ever Pharma, Isdorsia, Prevail Therapeutics, UCB, and received grants from Sanofi, the Michael J Fox Foundation, ANR, France Parkinson, the French Ministry of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}